In recent years, increasing studies have found that Trop-2 is highly expressed in multiple epithelial tumors, including lung, breast, gastric, and oral squamous cell carcinomas, while limited in normal tissues [16]. Here, TACSTD2 is linked to oral cavity squamous cell carcinoma.